Sales Growth YoY (Last 12 Months): Lyell Immunopharma (LYEL)

Public company logo of Lyell Pharma (LYEL)

The trailing twelve-month sales growth rate demonstrates current revenue dynamics, where the -63.20 mark characterizes this parameter. Lyell Immunopharma (LYEL) is creating an innovative oncology foundation by reprogramming T-cells to combat solid tumors. A lack of debt and a substantial cash reserve guarantee financial stability. However, the narrow specialization of the pipeline creates significant binary risks tied to clinical trial results.

Lyell Immunopharma, Inc. (LYEL) Revenue Growth YoY (Last 12 Months): for the period 02/11/2024 - 11/19/2026

Lyell Immunopharma, Inc. (LYEL) - metric breakdowns and financial figures

- market price and analyst price targets:
- company stock exchange capitalization indicators:
Summary company analytics:Lyell Immunopharma
Product sample of lyell.com

Lyell Immunopharma (LYEL) is implementing robotic systems to accelerate the development of T-cell therapies, moving the company into a stage of technological scaling. Analyzing the current sales growth rate over a rolling 12-month period year-over-year, the investor evaluates revenue dynamics through the lens of a TTM calculation, which neutralizes seasonality and reveals the actual trading momentum, determining the fundamental resilience of the business during its transition to commercialization.

Competitors of Lyell Immunopharma (LYEL)

Sales Growth YoY (TTM) NantKwest IBRX|IMCR - Sales Growth YoY (Last Twelve Months)|JANX (januxrx.com) - Sales Growth YoY (Last 12 Months)|Arcus Corp (RCUS) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Revenue Growth Zymeworks Corp (ZYME)|Revenue Growth YoY (Last 12 Months) TNGX|IOVA - Revenue Growth Rate YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) IMTX (Immatics Corp)|Revenue Change YoY (Last 12 Months) XNCR|Sales Growth YoY (TTM) CMPX (Compass Therapeutics, Inc.)|Revenue Dynamics YoY (Last Twelve Months) REPL|innate-pharma.com - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Pyxis Oncology|Compugen Limited (CGEN) - Sales Growth YoY (Last Twelve Months)|IO Biotech, Inc. - Revenue Dynamics YoY (Last Twelve Months)|STRO (sutrobio.com) - Sales Growth YoY (TTM)|Sales Growth YoY (TTM) MiNK Therapeutics Inc.|Sales Growth YoY (Last Twelve Months) werewolftx.com (HOWL)|IMMX: Trailing Twelve Months Sales Growth|alxoncology.com - Revenue Growth YoY (Last 12 Months)|CUE - Revenue Growth YoY (Last 12 Months)|PDSB - Sales Growth YoY (Last Twelve Months)|Annual Revenue Growth (Last Twelve Months) Sonnet BioTherapeutics Holdings SONN|MAIA: Sales Growth YoY (TTM)|LIMN - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) LVTX|Sales Growth YoY (Last 12 Months) NXTC (NextCure)|Sales Growth YoY (Last Twelve Months) leaptx.com (LPTX)|INTS - Trailing Twelve Months Revenue Growth|Sales Growth YoY (TTM) SNSE (Sensei Biotherapeutics, Inc.)|Annual Revenue Growth (Last Twelve Months) Theriva Biologics, Inc. (TOVX)|GRTS: Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) kinetabio.com KA|NEXI (neximmune.com) - Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth Turnstone Biologics Corporation (TSBX)|Revenue Growth YoY (Last 12 Months) VCNX|HARP: Revenue Dynamics YoY (Last Twelve Months)